The estimated Net Worth of Richard B Hancock is at least $3.39 Million dollars as of 14 December 2023. Mr. Hancock owns over 23,000 units of Avid Bioservices Inc stock worth over $1,973,726 and over the last 7 years he sold CDMOP stock worth over $638,556. In addition, he makes $774,947 as Director at Avid Bioservices Inc.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sign up
Mr. Hancock CDMOP stock SEC Form 4 insiders trading
Richard has made over 32 trades of the Avid Bioservices Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he bought 23,000 units of CDMOP stock worth $134,780 on 14 December 2023.
The largest trade he's ever made was buying 38,803 units of Avid Bioservices Inc stock on 13 December 2023 worth over $202,164. On average, Richard trades about 6,016 units every 39 days since 2017. As of 14 December 2023 he still owns at least 78,760 units of Avid Bioservices Inc stock.
You can see the complete history of Mr. Hancock stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Richard Hancock biography
Richard B. Hancock serves as Director of the Company. He was appointed to the Board of Directors pursuant to the Settlement Agreement on November 27, 2017. Mr. Hancock has worked in the biologic contract development and manufacturing organization (“CDMO”) industry for over 30 years in various operational and executive roles, serving most recently as President and CEO of Althea Technologies, Inc., a large molecule CDMO producing a wide range of biologics, vaccines and parenteral products. In addition to Althea, Mr. Hancock has held senior management positions at The Immune Response Corporation, and Hybritech Inc. (now part of Eli Lilly & Company), and he is currently the Chairman of the Board and Executive Director of Argonaut Manufacturing Services, Inc., a privately-owned CDMO focused on the biotechnology and life sciences industries. Mr. Hancock received a B.A. in Microbiology from Miami University. The Board of Directors concluded that Mr. Hancock should serve as a director in light of his extensive operational and executive management experience in the CDMO industry.
What is the salary of Richard Hancock?
As the Director of Avid Bioservices Inc, the total compensation of Richard Hancock at Avid Bioservices Inc is $774,947. There are 2 executives at Avid Bioservices Inc getting paid more, with Mark Ziebell having the highest compensation of $1,085,620.
How old is Richard Hancock?
Richard Hancock is 61, he's been the Director of Avid Bioservices Inc since 2020. There are 2 older and 7 younger executives at Avid Bioservices Inc. The oldest executive at Avid Bioservices Inc is Joseph Carleone, 74, who is the Independent Non-Executive Chairman of the Board.
What's Richard Hancock's mailing address?
Richard's mailing address filed with the SEC is 14191, Myford Road, Walnut, Tustin, Orange County, California, 92780, United States.
Insiders trading at Avid Bioservices Inc
Over the last 7 years, insiders at Avid Bioservices Inc have traded over $326,500 worth of Avid Bioservices Inc stock and bought 164,445 units worth $426,401 . The most active insiders traders include Gregory Sargen, Mark R Bamforth, and Richard B Hancock. On average, Avid Bioservices Inc executives and independent directors trade stock every 95 days with the average trade being worth of $895,669. The most recent stock trade was executed by Richard B Hancock on 10 September 2019, trading 10,000 units of CDMOP stock currently worth $50,900.
What does Avid Bioservices Inc's logo look like?
Complete history of Mr. Hancock stock trades at Avid Bioservices Inc and Avid Bioservices Inc
Avid Bioservices Inc executives and stock owners
Avid Bioservices Inc executives and other stock owners filed with the SEC include:
-
Mark Ziebell,
Vice President, General Counsel, Corporate Secretary -
Daniel Hart,
Chief Financial Officer -
Richard Hancock,
Director -
Catherine Mackey,
Independent Director -
Richard Richieri,
Chief Operations Officer -
Joseph Carleone,
Independent Non-Executive Chairman of the Board -
Gregory Sargen,
Independent Director -
Patrick Walsh,
Independent Director -
Mark Bamforth,
Independent Director -
Stephanie Diaz,
Investor Relations / Corporate Communications -
Timothy Compton,
Chief Commercial Officer -
Nicholas Green,
President, Chief Executive Officer, Director -
Roger J. Lias,
President & CEO -
Joel Mc Comb,
Director